Night blindness following low-dose isotretinoin

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 7, 2008, Pages 893-894

  Halpagi, P ^a   Grigg, J ^a   Klistorner, A ^a   Damian, Diona L ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DAPSONE; ERYTHROMYCIN; ETHAMBUTOL; ISONIAZID; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; RETINOL; RETINOL BINDING PROTEIN; RIFAMPICIN;

ACNE; ADULT; CASE REPORT; COLOR VISION; CONVALESCENCE; DETERIORATION; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTRORETINOGRAPHY; EYE REFRACTION; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; LUNG TUBERCULOSIS; NIGHT BLINDNESS; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITAMIN SUPPLEMENTATION;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADULT; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; NIGHT BLINDNESS;

EID: 45249120853     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02495.x     Document Type: Letter

References (6)

1. Fraunfelder FW. Ocular side effects associated with isotretinoin. Drugs Today (Barc) 2004; 40: 23-27.
2. Weleber RG, Denman ST, Hanifin JM, Cunningham WJ. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol 1986; 104: 831-837.
3. Mollan SP, Woodcock M, Siddiqi R, Huntbach J, Good P, Scott RA. Does use of isotretinoin rule out a career in flying? Br J Ophthalmol 2006; 90: 957-959.
4. Brown M, Marmor M, Vaegan, Zrenner E, Brigell M, Bach M. ISCEV standard for clinical electro-oculography (EOG) 2006. Doc Ophthalmol 2006; 113: 205-212.
5. Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun 1989; 161: 825-829.
6. Welsh BM, Smith AL, Elder JE, Varigos GA. Night blindness precipitated by isotretinoin in the setting of hypovitaminosis A. Australas J Dermatol 1999; 40: 208-210.